Please provide your email address to receive an email when new articles are posted on . BlueRock Therapeutics is preparing to initiate a phase 1/2a clinical study of OpCT-001. OpCT-001 will be ...

Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with ...

Blinding diseases lead to permanent vision loss by damaging photoreceptor cells, which humans cannot naturally regenerate. While researchers are working on new methods to replace or regenerate these ...

Calcium sensor proteins are fundamental modulators of photoreceptor cell function, where they detect fluctuations in intracellular Ca²⁺ levels to finely tune the phototransduction cascade. These ...

For the first time, an international research team led by Nanyang Technological University, Singapore (NTU Singapore) has ...